📐 SOP for Rounding Rules for Calculation of Results (IP & USP)

---

1. Introduction

Rounding rules ensure analytical results are reported consistently and correctly interpreted against compendial limits. This SOP describes rounding rules as per Indian Pharmacopoeia (IP) and United States Pharmacopeia (USP). Acceptance criteria are fixed numbers and must not be rounded.

2. Purpose

To establish a systematic procedure for rounding numerical results and interpreting assay and limit test values as per IP and USP.

3. Scope

This SOP applies to all analytical testing results for which rounding is required before reporting, including assay and limit tests, in the QC laboratory.

4. Responsibilities

• QC Analyst: Perform calculations, round values, and document results correctly.
• QC Supervisor: Verify rounding and calculation compliance with IP/USP rules.
• QA / QC Head: Approve the SOP and periodic compliance checks.

5. Definitions

• Unrounded Value: The exact numerical value obtained from calculation before any rounding.
• Rounded Result: The value rounded for reporting according to compendial decimal requirements.
• Acceptance Criteria: Fixed compendial limits that must not be rounded.
• Limit Test: Test specifying the maximum permissible level of impurities, e.g., ≤0.02% or ≤3 ppm.
• Assay: Quantitative determination of active pharmaceutical ingredient (API) content in a sample.

6. Procedure

1. Perform the Analytical Test: Conduct the assay or limit test according to the approved method.
2. Complete Calculations: Carry out all calculations fully without rounding intermediate values.
3. Determine Unrounded Result: Obtain the final numerical result using full precision.
4. Compare with Acceptance Criteria: Check the unrounded value against compendial limits (IP or USP).
5. Decide Compliance: Make the pass/fail decision using the unrounded result; do not round the specification limit.
6. Apply Rounding for Reporting Only:
   • Identify the last decimal place in the specification limit.
   • If the next digit is 4 or less, drop it.
   • If the next digit is 5 or more, increase the preceding digit by 1.
7. Document Results: Record both unrounded and rounded values in the analytical report or LIMS.
8. Verify Compliance: QC Supervisor must review calculations and rounding for correctness.
9. Maintain Records: Ensure full traceability of results, rounding, and comparison with limits.

7. Table 1 – Illustration of Rounding (Indian Pharmacopoeia)

Compendial Requirement	Unrounded Value	Rounded Result	Conforms
Assay limit ≥ 98.0%	97.96%	98.0%	Yes
Assay limit ≥ 98.0%	97.92%	97.9%	No
Assay limit ≥ 98.0%	97.95%	98.0%	Yes
Assay limit ≤ 101.5%	101.55%	101.6%	No
Assay limit ≤ 101.5%	101.46%	101.5%	Yes
Assay limit ≤ 101.5%	101.45%	101.5%	Yes
Limit test ≤ 0.02%	0.025%	0.03%	No
Limit test ≤ 0.02%	0.015%	0.02%	Yes
Limit test ≤ 0.02%	0.027%	0.03%	No
Limit test ≤ 3 ppm	3.5 ppm	4 ppm	No
Limit test ≤ 3 ppm	3.4 ppm	3 ppm	Yes
Limit test ≤ 3 ppm	2.5 ppm	3 ppm	Yes

8. Table 2 – Illustration of Rounding (USP)

Compendial Requirement	Unrounded Value	Rounded Result	Conforms
Assay limit ≥ 98.0%	97.96%	98.0%	Yes
Assay limit ≥ 98.0%	97.92%	97.9%	No
Assay limit ≥ 98.0%	97.95%	98.0%	Yes
Assay limit ≤ 101.5%	101.55%	101.6%	No
Assay limit ≤ 101.5%	101.46%	101.5%	Yes
Assay limit ≤ 101.5%	101.45%	101.5%	Yes
Limit test ≤ 0.02%	0.025%	0.03%	No
Limit test ≤ 0.02%	0.015%	0.02%	Yes
Limit test ≤ 0.02%	0.027%	0.03%	No
Limit test ≤ 3 ppm	3.5 ppm	4 ppm	No
Limit test ≤ 3 ppm	3.4 ppm	3 ppm	Yes
Limit test ≤ 3 ppm	2.5 ppm	3 ppm	Yes

9. References

• Indian Pharmacopoeia – General Notices
• United States Pharmacopeia – General Notices (Expression of Numerical Results)
• USP <1225> Validation of Compendial Procedures
• IP & USP Individual Monographs

© 2025 sopnest.blogspot.com. All rights reserved. This content is independently written and intended for educational purposes. References to regulatory guidelines are for compliance guidance only.